In vitro stimulation of insulin release by SL 84.0418, a new α2-adrenoceptor antagonist-Reference-Cited by-同舟云学术

In vitro stimulation of insulin release by SL 84.0418, a new α2-adrenoceptor antagonist

Published:1994-03 Issue:1-2 Volume:254 Page:27-33
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Jonas Jean-Christophe,Plant Timothy D.,Angel Itzchak,Langer Salomon Z.,Henquin Jean-Claude

Publisher

Elsevier BV

Subject

Pharmacology

Reference37 articles.

1. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion;Ahren;Diabetologia,1986

2. SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile;Angel;J. Pharmacol. Exp. Ther.,1992

3. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active α2-adrenoceptor antagonist;Angel;Eur. J. Pharamcol.,1993

4. The new alpha-2 adrenoceptor blocking compound (SL 84.0418) inhibits blood glucose increase following oral glucose tolerance test in healthy subjects;Berlin;Diabetologia,1992

5. Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-unsulin-dependent diabetes mellitus;Broadstone;Diabetes,1987

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adrenoceptor Expression and Function in the Endocrine Pancreas;Handbook of Experimental Pharmacology;2024

2. Methylamine Activates Glucose Uptake in Human Adipocytes Without Overpassing Action of Insulin or Stimulating its Secretion in Pancreatic Islets;Medicines;2019-08-12

3. α 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal;Letters in Drug Design & Discovery;2009-03-01

4. Agonists and Antagonists Targeting the Different α2-Adrenoceptor Subtypes;Current Topics in Medicinal Chemistry;2007-01-01

5. α2-Adrenoceptor antagonist SL 84.0418 reduces the expression of neocortical spike-and-wave spindling episodes in DBA/2J mice;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2003-02